Nevamed

1 ml of the drug contains:

• active substance: nepafenac 3 mg.

• prevention and treatment of postoperative pain and inflammation during cataract surgery;
• reducing the risk of developing postoperative macular edema during cataract surgery in patients with diabetes.

Directions for use and dosage: For topical use only. The bottle must be shaken before use.

• For the prevention and treatment of postoperative pain and inflammation after cataract removal, the drug is instilled 1 drop into the conjunctival sac of the eye once a day, if necessary up to 3 times a day. Treatment begins 1 day before cataract surgery and continues for the first 2 weeks of the postoperative period (including the day of surgery). An additional drop of the drug must be instilled 30-120 minutes before surgery.
• To reduce the risk of developing postoperative macular edema after cataract removal in patients with diabetes instill 1 drop into the conjunctival sac of the eye 1 time per day, starting from the first day before cataract removal, on the day of surgery, further dosing regimen and duration of treatment are prescribed by the attending physician. An additional drop of the drug must be instilled 30-120 minutes before surgery.